Neighborhood-level deprivation and survival in lung cancer.
DNA methylation
Disparities
Epigenetic
Lung cancer
Neighborhood-level deprivation
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
06 Aug 2024
06 Aug 2024
Historique:
received:
28
05
2024
accepted:
29
07
2024
medline:
7
8
2024
pubmed:
7
8
2024
entrez:
6
8
2024
Statut:
epublish
Résumé
Despite recent advances in lung cancer therapeutics and improving overall survival, disparities persist among socially disadvantaged populations. This study aims to determine the effects of neighborhood deprivation indices (NDI) on lung cancer mortality. This is a multicenter retrospective cohort study assessing the relationship between NDI and overall survival adjusted for age, disease stage, and DNA methylation among biopsy-proven lung cancer patients. State-specific NDI for each year of sample collection were computed at the U.S. census tract level and dichotomized into low- and high-deprivation. A total of 173 non small lung cancer patients were included, with n = 85 (49%) and n = 88 (51%) in the low and high-deprivation groups, respectively. NDI was significantly higher among Black patients when compared with White patients (p = 0.003). There was a significant correlation between DNA methylation and stage for HOXA7, SOX17, ZFP42, HOXA9, CDO1 and TAC1. Only HOXA7 DNA methylation was positively correlated with NDI. The high-deprivation group had a statistically significant shorter survival than the low-deprivation group (p = 0.02). After adjusting for age, race, stage, and DNA methylation status, belonging to the high-deprivation group was associated with higher mortality with a hazard ratio of 1.81 (95%CI: 1.03-3.19). Increased neighborhood-level deprivation may be associated with liquid biopsy DNA methylation, shorter survival, and increased mortality. Changes in health care policies that consider neighborhood-level indices of socioeconomic deprivation may enable a more equitable increase in lung cancer survival.
Sections du résumé
BACKGROUND
BACKGROUND
Despite recent advances in lung cancer therapeutics and improving overall survival, disparities persist among socially disadvantaged populations. This study aims to determine the effects of neighborhood deprivation indices (NDI) on lung cancer mortality. This is a multicenter retrospective cohort study assessing the relationship between NDI and overall survival adjusted for age, disease stage, and DNA methylation among biopsy-proven lung cancer patients. State-specific NDI for each year of sample collection were computed at the U.S. census tract level and dichotomized into low- and high-deprivation.
RESULTS
RESULTS
A total of 173 non small lung cancer patients were included, with n = 85 (49%) and n = 88 (51%) in the low and high-deprivation groups, respectively. NDI was significantly higher among Black patients when compared with White patients (p = 0.003). There was a significant correlation between DNA methylation and stage for HOXA7, SOX17, ZFP42, HOXA9, CDO1 and TAC1. Only HOXA7 DNA methylation was positively correlated with NDI. The high-deprivation group had a statistically significant shorter survival than the low-deprivation group (p = 0.02). After adjusting for age, race, stage, and DNA methylation status, belonging to the high-deprivation group was associated with higher mortality with a hazard ratio of 1.81 (95%CI: 1.03-3.19).
CONCLUSIONS
CONCLUSIONS
Increased neighborhood-level deprivation may be associated with liquid biopsy DNA methylation, shorter survival, and increased mortality. Changes in health care policies that consider neighborhood-level indices of socioeconomic deprivation may enable a more equitable increase in lung cancer survival.
Identifiants
pubmed: 39107707
doi: 10.1186/s12885-024-12720-w
pii: 10.1186/s12885-024-12720-w
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
959Informations de copyright
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: Cancer J Clin 2024.
SEER Cancer Statistics Review (CSR.) 1975–2018 [ https://seer.cancer.gov/csr/1975_2018/]
Diez Roux AV. Investigating neighborhood and area effects on health. Am J Public Health. 2001;91(11):1783–9.
pubmed: 11684601
pmcid: 1446876
doi: 10.2105/AJPH.91.11.1783
Cockerham WC, Hamby BW, Oates GR. The Social determinants of Chronic Disease. Am J Prev Med. 2017;52(1S1):S5–12.
pubmed: 27989293
pmcid: 5328595
doi: 10.1016/j.amepre.2016.09.010
Galiatsatos P, Woo H, Paulin LM, Kind A, Putcha N, Gassett AJ, Cooper CB, Dransfield MT, Parekh TM, Oates GR, et al. The Association between Neighborhood Socioeconomic Disadvantage and Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:981–93.
pubmed: 32440110
pmcid: 7211318
doi: 10.2147/COPD.S238933
Singh GK, Jemal A. Socioeconomic and Racial/Ethnic disparities in Cancer Mortality, incidence, and Survival in the United States, 1950–2014: over six decades of changing patterns and widening inequalities. J Environ Public Health 2017, 2017:2819372.
Adie Y, Kats DJ, Tlimat A, Perzynski A, Dalton J, Gunzler D, Tarabichi Y. Neighborhood Disadvantage and Lung Cancer incidence in ever-smokers at a Safety Net Health-Care System: a retrospective study. Chest. 2020;157(4):1021–9.
pubmed: 31862438
doi: 10.1016/j.chest.2019.11.033
Hulbert A, Jusue-Torres I, Stark A, Chen C, Rodgers K, Lee B, Griffin C, Yang A, Huang P, Wrangle J, et al. Early detection of Lung Cancer using DNA promoter hypermethylation in plasma and Sputum. Clin Cancer Res. 2017;23(8):1998–2005.
pubmed: 27729459
doi: 10.1158/1078-0432.CCR-16-1371
Liu B, Ricarte Filho J, Mallisetty A, Villani C, Kottorou A, Rodgers K, Chen C, Ito T, Holmes K, Gastala N, et al. Detection of promoter DNA methylation in urine and plasma aids the detection of Non-small Cell Lung Cancer. Clin Cancer Res. 2020;26(16):4339–48.
pubmed: 32430478
pmcid: 7442601
doi: 10.1158/1078-0432.CCR-19-2896
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, et al. NCCN Guidelines(R) Insights: Non-small Cell Lung Cancer, Version 2.2023. J Natl Compr Canc Netw. 2023;21(4):340–50.
pubmed: 37015337
doi: 10.6004/jnccn.2023.0020
Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, Le Marchand L. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354(4):333–42.
pubmed: 16436765
doi: 10.1056/NEJMoa033250
DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African americans, 2019. CA Cancer J Clin. 2019;69(3):211–33.
doi: 10.3322/caac.21555
Armstrong K, Ravenell KL, McMurphy S, Putt M. Racial/ethnic differences in physician distrust in the United States. Am J Public Health. 2007;97(7):1283–9.
pubmed: 17538069
pmcid: 1913079
doi: 10.2105/AJPH.2005.080762
Mullins MA, Peres LC, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, Bondy ML, Funkhouser E, Moorman PG, Peters ES, Terry PD, et al. Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study. Cancer. 2019;125(24):4442–51.
pubmed: 31415710
doi: 10.1002/cncr.32451
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.
doi: 10.1016/S0140-6736(07)61602-X
R Core Team. In: Vienna, editor. R: a Language and Environment for Statistical Computing. Austria: R Foundation for Statistical Computing; 2022.
Budler ID. Ndi: Neighborhood Deprivation Indices. The Comprehensive R Archive Network 2022, v0.1.2.
Messer LC, Laraia BA, Kaufman JS, Eyster J, Holzman C, Culhane J, Elo I, Burke JG, O’Campo P. The development of a standardized neighborhood deprivation index. J Urban Health. 2006;83(6):1041–62.
pubmed: 17031568
pmcid: 3261293
doi: 10.1007/s11524-006-9094-x
Andrews MR, Tamura K, Claudel SE, Xu S, Ceasar JN, Collins BS, Langerman S, Mitchell VM, Baumer Y, Powell-Wiley TM. Geospatial analysis of Neighborhood Deprivation Index (NDI) for the United States by County. J Maps. 2020;16(1):101–12.
pubmed: 32855653
pmcid: 7447192
doi: 10.1080/17445647.2020.1750066
Slotman BA, Stinchcomb DG, Powell-Wiley TM, Ostendorf DM, Saelens BE, Gorin AA, Zenk SN, Berrigan D. Environmental data and methods from the Accumulating Data to optimally predict obesity treatment (ADOPT) core measures environmental working group. Data Brief. 2022;41:108002.
pubmed: 35300389
pmcid: 8920874
doi: 10.1016/j.dib.2022.108002
Diez Roux AV, Mair C. Neighborhoods and health. Ann N Y Acad Sci. 2010;1186:125–45.
pubmed: 20201871
doi: 10.1111/j.1749-6632.2009.05333.x
Shen J, Fuemmeler BF, Sheppard VB, Bear HD, Song R, Chow WH, Zhao H. Neighborhood disadvantage and biological aging biomarkers among breast cancer patients. Sci Rep. 2022;12(1):11006.
pubmed: 35773311
pmcid: 9246873
doi: 10.1038/s41598-022-15260-0
Lawrence KG, Kresovich JK, O’Brien KM, Hoang TT, Xu Z, Taylor JA, Sandler DP. Association of Neighborhood Deprivation with Epigenetic Aging using 4 Clock Metrics. JAMA Netw Open. 2020;3(11):e2024329.
pubmed: 33146735
pmcid: 7643028
doi: 10.1001/jamanetworkopen.2020.24329
Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. N Engl J Med. 2018;378(26):2456–8.
pubmed: 29949490
pmcid: 6051533
doi: 10.1056/NEJMp1802313
Diez Roux AV, Borrell LN, Haan M, Jackson SA, Schultz R. Neighbourhood environments and mortality in an elderly cohort: results from the cardiovascular health study. J Epidemiol Community Health. 2004;58(11):917–23.
pubmed: 15483307
doi: 10.1136/jech.2003.019596
Panczak R, Galobardes B, Voorpostel M, Spoerri A, Zwahlen M, Egger M, Swiss National C. Swiss Household P: a Swiss neighbourhood index of socioeconomic position: development and association with mortality. J Epidemiol Community Health. 2012;66(12):1129–36.
pubmed: 22717282
doi: 10.1136/jech-2011-200699
Li X, Sundquist J, Zoller B, Sundquist K. Neighborhood deprivation and lung cancer incidence and mortality: a multilevel analysis from Sweden. J Thorac Oncol. 2015;10(2):256–63.
pubmed: 25376515
doi: 10.1097/JTO.0000000000000417
Mancilla VJ, Peeri NC, Silzer T, Basha R, Felini M, Jones HP, Phillips N, Tao MH, Thyagarajan S, Vishwanatha JK. Understanding the Interplay between Health Disparities and Epigenomics. Front Genet. 2020;11:903.
pubmed: 32973872
pmcid: 7468461
doi: 10.3389/fgene.2020.00903
Alcaraz KI, Wiedt TL, Daniels EC, Yabroff KR, Guerra CE, Wender RC. Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy. CA Cancer J Clin. 2020;70(1):31–46.
pubmed: 31661164
doi: 10.3322/caac.21586
Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by Cancer survivors: a systematic review. J Natl Cancer Inst 2017, 109(2).
Friedes C, Hazell SZ, Fu W, Hu C, Voong RK, Lee B, Feliciano JL, Nicholas LH, McNutt TR, Han P, et al. Longitudinal trends of Financial toxicity in patients with Lung Cancer: a prospective cohort study. JCO Oncol Pract. 2021;17(8):e1094–109.
pubmed: 33555936
doi: 10.1200/OP.20.00721
Lee A, Shah K, Chino F. Assessment of parking fees at National Cancer Institute-Designated Cancer Treatment Centers. JAMA Oncol. 2020;6(8):1295–7.
pubmed: 32672809
pmcid: 7366280
doi: 10.1001/jamaoncol.2020.1475
Chino F, Zafar SY. Financial Toxicity and Equitable Access to clinical trials. Am Soc Clin Oncol Educ Book. 2019;39:11–8.
pubmed: 31099681
doi: 10.1200/EDBK_100019
Richardson AS, Troxel WM, Ghosh-Dastidar M, Hunter GP, Beckman R, Colabianchi N, Collins RL, Dubowitz T. Pathways through which higher neighborhood crime is longitudinally associated with greater body mass index. Int J Behav Nutr Phys Act. 2017;14(1):155.
pubmed: 29121957
pmcid: 5679366
doi: 10.1186/s12966-017-0611-y
van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, et al. Effect of low-intensity physical activity and moderate- to High-Intensity Physical Exercise during Adjuvant Chemotherapy on physical fitness, fatigue, and Chemotherapy Completion Rates: results of the PACES Randomized Clinical Trial. J Clin Oncol. 2015;33(17):1918–27.
pubmed: 25918291
doi: 10.1200/JCO.2014.59.1081
Bortolato B, Hyphantis TN, Valpione S, Perini G, Maes M, Morris G, Kubera M, Kohler CA, Fernandes BS, Stubbs B, et al. Depression in cancer: the many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2017;52:58–70.
pubmed: 27894012
doi: 10.1016/j.ctrv.2016.11.004
Obeng-Gyasi S, Graham N, Kumar S, Lee JW, Jacobus S, Weiss M, Cella D, Zhao F, Ip EH, O’Connell N, et al. Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients. Blood Cancer J. 2022;12(4):53.
pubmed: 35365604
pmcid: 8975964
doi: 10.1038/s41408-022-00648-y
Rojewski AM, Tanner NT, Dai L, Ravenel JG, Gebregziabher M, Silvestri GA, Toll BA. Tobacco Dependence predicts higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018;154(1):110–8.
pubmed: 29793736
pmcid: 6045783
doi: 10.1016/j.chest.2018.04.016
Edwards CV, Sheikh AR, Dennis MJ, Hunter A, Mackay ZP, Catudal EC, Elias R, Cabral HJ, Sarosiek SR, Tapan U. The impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancer. J Thorac Dis. 2022;14(10):3865–75.
pubmed: 36389291
pmcid: 9641327
doi: 10.21037/jtd-21-1992
Nawrot TS, Martens DS, Hara A, Plusquin M, Vangronsveld J, Roels HA, Staessen JA. Association of total cancer and lung cancer with environmental exposure to cadmium: the meta-analytical evidence. Cancer Causes Control. 2015;26(9):1281–8.
pubmed: 26109463
doi: 10.1007/s10552-015-0621-5
Li J, Li WX, Bai C, Song Y. Particulate matter-induced epigenetic changes and lung cancer. Clin Respir J. 2017;11(5):539–46.
pubmed: 26403658
doi: 10.1111/crj.12389
Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, Kuan FC, Marongiu F, Evans EJ Jr., Moore DA, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159–67.
pubmed: 37020004
pmcid: 7614604
doi: 10.1038/s41586-023-05874-3
Lam LL, Emberly E, Fraser HB, Neumann SM, Chen E, Miller GE, Kobor MS. Factors underlying variable DNA methylation in a human community cohort. Proc Natl Acad Sci U S A. 2012;109(Suppl 2):17253–60.
pubmed: 23045638
pmcid: 3477380
doi: 10.1073/pnas.1121249109
Tehranifar P, Wu HC, Fan X, Flom JD, Ferris JS, Cho YH, Gonzalez K, Santella RM, Terry MB. Early life socioeconomic factors and genomic DNA methylation in mid-life. Epigenetics. 2013;8(1):23–7.
pubmed: 23196856
pmcid: 3549876
doi: 10.4161/epi.22989
Needham BL, Smith JA, Zhao W, Wang X, Mukherjee B, Kardia SL, Shively CA, Seeman TE, Liu Y, Diez Roux AV. Life course socioeconomic status and DNA methylation in genes related to stress reactivity and inflammation: the multi-ethnic study of atherosclerosis. Epigenetics. 2015;10(10):958–69.
pubmed: 26295359
pmcid: 4844216
doi: 10.1080/15592294.2015.1085139
Swartz JR, Hariri AR, Williamson DE. An epigenetic mechanism links socioeconomic status to changes in depression-related brain function in high-risk adolescents. Mol Psychiatry. 2017;22(2):209–14.
pubmed: 27217150
doi: 10.1038/mp.2016.82
McDade TW, Ryan C, Jones MJ, MacIsaac JL, Morin AM, Meyer JM, Borja JB, Miller GE, Kobor MS, Kuzawa CW. Social and physical environments early in development predict DNA methylation of inflammatory genes in young adulthood. Proc Natl Acad Sci U S A. 2017;114(29):7611–6.
pubmed: 28673994
pmcid: 5530653
doi: 10.1073/pnas.1620661114
Santos HP Jr., Bhattacharya A, Martin EM, Addo K, Psioda M, Smeester L, Joseph RM, Hooper SR, Frazier JA, Kuban KC, et al. Epigenome-wide DNA methylation in placentas from preterm infants: association with maternal socioeconomic status. Epigenetics. 2019;14(8):751–65.
pubmed: 31062658
pmcid: 6615526
doi: 10.1080/15592294.2019.1614743
Laubach ZM, Perng W, Cardenas A, Rifas-Shiman SL, Oken E, DeMeo D, Litonjua AA, Duca RC, Godderis L, Baccarelli A, et al. Socioeconomic status and DNA methylation from birth through mid-childhood: a prospective study in Project viva. Epigenomics. 2019;11(12):1413–27.
pubmed: 31509016
pmcid: 6802709
doi: 10.2217/epi-2019-0040
Yannatos I, Stites S, Brown RT, McMillan CT. Contributions of neighborhood social environment and air pollution exposure to Black-White disparities in epigenetic aging. PLoS ONE. 2023;18(7):e0287112.
pubmed: 37405974
pmcid: 10321643
doi: 10.1371/journal.pone.0287112
Baccarelli A, Tarantini L, Wright RO, Bollati V, Litonjua AA, Zanobetti A, Sparrow D, Vokonas PS, Schwartz J. Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics. 2010;5(3):222–8.
pubmed: 20305373
doi: 10.4161/epi.5.3.11377
Nwanaji-Enwerem JC, Colicino E, Trevisi L, Kloog I, Just AC, Shen J, Brennan K, Dereix A, Hou L, Vokonas P et al. Long-term ambient particle exposures and blood DNA methylation age: findings from the VA normative aging study. Environ Epigenet 2016, 2(2).
Huang SK, Tripathi P, Koneva LA, Cavalcante RG, Craig N, Scruggs AM, Sartor MA, Deng F, Chen Y. Effect of concentration and duration of particulate matter exposure on the transcriptome and DNA methylome of bronchial epithelial cells. Environ Epigenetics. 2021;7(1):dvaa022.
doi: 10.1093/eep/dvaa022
Wu H, Eckhardt CM, Baccarelli AA. Molecular mechanisms of environmental exposures and human disease. Nat Rev Genet. 2023;24(5):332–44.
pubmed: 36717624
pmcid: 10562207
doi: 10.1038/s41576-022-00569-3